ad

MedPlus Health Services Gears Up for Q3 Reveal on 30th January; Check Key Expectations Here

Posted by : sachet | Thu Jan 29 2026

MedPlus Health Services Gears Up for Q3 Reveal on 30th January; Check Key Expectations Here

Click and Sign Up to Get Live Updates on Q3 Results 

MedPlus Health Services’s Q3 results FY26 are scheduled to be announced on 30th January 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.

MedPlus Health Services Q3 Results 2026 Preview

  • MedPlus Health Services’ revenue is expected to be in the range of ₹7,049.57  crore, a 15% YoY increase. 
  • Profit After Tax, or PAT, is projected to rise by 7% YoY. 
  • Net profit is ₹1,434.84 crore, a fall 25.15% YoY 
  • EBITDA to fall 16.78%

MedPlus Health Services Share Performance 

  • Over the past six months, MedPlus Health Services’ share price has fallen by 8.95% to ₹28.00.
  • Moreover, over the past year, the stock has increased by 12.87%.
  • Despite this weak short-term performance, MedPlus Health Services’ stock has delivered a financially sound 239.85% return over the past 5 years.
  • As of 29th January 2026, the stock traded at ₹28.00 per share.

Key Factors to Watch for MedPlus Health Services Q3 Results FY26 

  • Loan Growth & Disbursements: Track growth in home loans, loan-against-property, and quarterly disbursements.
  • Net Interest Income & Margins: Monitor NII and NIM trends amid rate changes and competition.
  • Asset Quality & Provisions: Assess GNPA/Stage-3 ratios, recoveries, and provisioning impact on earnings.
  • Operating Efficiency: Watch the cost-to-income ratio and overall operational efficiency.
  • Segment Mix & Strategy: Evaluate contributions from affordable housing, LAP/LRD, and other non-housing segments.

Final Thoughts

MedPlus Health Services will announce its Q3 FY26 results on 30th January 2026. Analysts expect 4.30% YoY revenue growth, a 1.67% rise in PAT, and a 4.33% fall in EBITDA. MedPlus Health Services focuses on operating India’s largest omni-channel pharmacy retail and healthcare services network — selling prescription and OTC medicines, wellness and FMCG products through its extensive store network and online platforms, while also offering diagnostics and allied health services.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Recent Articles

Capital Small Finance Bank Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Carborundum Universal Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Capri Global Capital Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Digitide Solutions Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Flair Writing Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

GHCL Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apar Industries Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here

Apollo Pipes Gears Up for Q3 Reveal on 29th January; Check Key Expectations Here